Login

Join Now

Recent BioUtah News & Events

Everything Happening in Utah Life Sciences

December 20, 2023
BioUtah News
Spectrum Solutions Names Bill Phillips as New Chief Executive Officer

Spectrum Solutions Names Bill Phillips as New Chief Executive Officer

December 20, 2023
BioUtah News
MasterControl Solutions Inc., Expands in Salt Lake County

$40 million capex, 155 jobs, Project Orange

December 14, 2023
BioUtah News
Halia Therapeutics Dosed its First Patient in Phase 2a Clinical Trial of HT-6184, a First-in-Class NLRP3-Inhibitor, for the Treatment of Lower-Risk Myelodysplastic Syndromes

LEHI, Utah /PRNewswire/ — Halia Therapeutics, a clinical-stage biopharmaceutical company pioneering a novel class of small molecule medications designed to combat inflammation, today announced the dosing of the first patient in Phase 2a clinical trial evaluating its lead candidate, HT-6184, for the treatment of lower-risk myelodysplastic syndromes (LR-MDS). HT-6184 is a selective and orally bioavailable first-in-class […]

December 14, 2023
BioUtah News
BD Receives FDA 510(k) Clearance for Potentially Transformative Fingertip Blood Collection Device

BD MiniDraw™ Capillary Blood Collection System Enables Lab-Quality Blood Testing from Less Invasive Method than Venous Collection in More Convenient Locations

December 14, 2023
BioUtah News
Halia Therapeutics co-founder David J. Bearss Featured in Utah Business

Utah Business recently featured Halia Therapeutics co-founder David Bearss in their Founder Series

December 7, 2023
BioUtah News
RxCell Announces $4.6M Investment from DMR Global Venture and Regenosis, Plans for Second Raise of $15M for IND Testing in Q4 2023

SINGAPORE–(BUSINESS WIRE)–RxCell, a pioneering biotech company focusing on cellular therapeutics for age-related diseases, today proudly announces a $4,600,000 investment commitment from DMR Global Venture LLC and Regenosis. Building on the strength of collaboration with National University of Singapore, this fresh investment accentuates RxCell’s resolute drive to revolutionize age-related disease treatment. “We’re thrilled to align with […]

December 7, 2023
BioUtah News
Culmination Bio Raises $10M From Amgen Ventures and Merck Global Health Innovation Fund to Bring Longitudinal Health Data to Biopharma

Culmination Bio has over 40 years of biospecimen data and counting, paired with clinical data from patient EHRs, making recruitment for pharmaceutical research almost instantaneous. St. George, Utah — (November 30, 2023) — Culmination Bio, a company building the largest disease-agnostic patient data intelligence platform, today announced a $10 million investment from Merck Global Health […]

December 7, 2023
BioUtah News
SERA PROGNOSTICS ANNOUNCES PRIMARY ENDPOINT CRITERIA MET IN PIVOTAL PRIME STUDY INTERIM LOOK – ENROLLMENT TO STOP DUE TO SUCCESS

SALT LAKE CITY, Dec. 6, 2023 /PRNewswire/ — Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced that the Data Safety Monitoring Board (DSMB) overseeing its pivotal Prematurity Risk Assessment Combined with Clinical Interventions for Improved Neonatal […]

December 7, 2023
BioUtah News
BD to Present Next Installment of BD Innovates Series: Spotlight on Pharmaceutical Systems

BD to Present Next Installment of BD Innovates Series: Spotlight on Pharmaceutical Systems

November 30, 2023
BioUtah News
Next-Generation Microcatheter for Embolic Agent Delivery Cleared by the FDA

Next-Generation Microcatheter for Embolic Agent Delivery Cleared by the FDA

November 30, 2023
BioUtah News
BD Launches Advanced Vascular Access Ultrasound System Designed to Improve Clinician Efficiency

SiteRite™ 9 Ultrasound System Delivers Enhanced Image Quality and Vessel Assessment Tools to Aid in First Attempt IV Insertion Success

November 30, 2023
BioUtah News
Seek Labs Announces Completion of Office Expansion to Support Business Growth

Seek Labs Announces Completion of Office Expansion to Support Business Growth

November 30, 2023
BioUtah News
Biolexis Therapeutics launches subsidiary Metabolexis to develop novel oral medicines for Obesity and Type 2 Diabetes to improve human longevity

Metabolexis focuses on GLP-1 weight loss and type 2 diabetic drug discoveries to improve accessibility and meet unprecedented demand.

November 30, 2023
BioUtah News
Biolexis Secures $10 Million in Series A Funding to Advance Metabolic Drug Development

LED BY CLARKE CAPITAL, THE NEW FUNDING ROUND WILL ACCELERATE THE COMPANY’S DRUG DISCOVERY PIPELINE

November 30, 2023
BioUtah News
Myriad Genetics Celebrates One Million SneakPeek® Results Shared with Expectant Parents

Myriad Genetics Celebrates One Million SneakPeek® Results Shared with Expectant Parents

November 30, 2023
BioUtah News
Halia Therapeutics Announces Positive Phase 1 Clinical Trial Results for HT-6184 at the 5th Inflammasome Therapeutics Summit

Halia Therapeutics Announces Positive Phase 1 Clinical Trial Results for HT-6184 at the 5th Inflammasome Therapeutics Summit

November 16, 2023
BioUtah News
Myriad Genetics and Personalis Partner to Market Solutions to Pharma Customers

Myriad expands pharma service offering by introducing Personalis’ ImmunoID NeXT® platform to its pharmaceutical partners who use MyRisk® Hereditary Cancer Test, BRACAnalysis CDx® and/or MyChoice® CDx cancer tests

November 16, 2023
BioUtah News
Innovative Research, Inclusive Trials, and New Funding Drives Hope for People with Parkinson’s Disease

PhotoPharmics Secures $16 Million Investment Led by Kickstart to Fund Pivotal Clinical Trial for FDA Market Authorization

November 16, 2023
Policy News
Seek Labs Unveils SeekIt™

Seek Labs’ integrated molecular diagnostic platform brings true point-of-care testing to the patient.

November 9, 2023
BioUtah News
2023 Utah Life Sciences Summit Recap and Gallery

BioUtah yesterday held its 2023 Utah Life Sciences Summit, presented by Mayer Brown. Every year, the Summit is the largest gathering of Utah’s life sciences industry. This year was no exception. Following welcome remarks from Gov. Spencer Cox, a distinguished line-up of top executives addressed a packed house. Keynote speaker, Joseph Smith, chief scientific officer […]

November 9, 2023
BioUtah News
November 2, 2023
BioUtah News
2023 BioUtah Life Sciences Awards to be Presented at the Mayer Brown Utah Life Sciences Summit

SALT LAKE CITY – November 3, 2023 – BioUtah today announced the winners of its 2023 Life Sciences Awards. Five awards will be presented during the 2023 Mayer Brown Utah Life Sciences Summit Nov. 9 at the Salt Palace, in Salt Lake City. BioUtah’s annual awards recognize leaders, innovators and entrepreneurs who have made significant […]

November 2, 2023
BioUtah News
ATL Announces New VP of Human Resources

Springville, Utah, October 27, 2023—ATL Technology, a dynamic and rapidly expanding company specializing in medical device development and manufacturing, is thrilled to introduce Danelle Goulet as the new Vice President of Human Resources. Expressing her enthusiasm for her new role, Danelle shared, “I am excited by the challenge of a fast-growing company in the medical […]

November 2, 2023
BioUtah News
BD Introduces Advanced Ultrasound Technology to Help Drive First-Stick Success for IV Insertions

BD Prevue™ II System Equips Clinicians with Connected Ultrasound Technology to Drive More Intuitive IV Placement and Control FRANKLIN LAKES, N.J. (April 11, 2023) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today launched a new, easy-to-use advanced ultrasound device with a specialized probe designed to provide clinicians with […]